Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

NIH 5OTHER 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Oligodendroglioma 1Neoplasms, Plasma Cell 1Lymphoma 1Leukemia 1Hodgkin Disease 1Hematologic Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Cyclophosphamide 415Radiotherapy 274fludarabine 237Gemcitabine 210Cisplatin 202Nivolumab 184pembrolizumab 181Paclitaxel 176Carboplatin 167Magnetic Resonance Spectroscopy 163fludarabine phosphate 156Irinotecan 134Bevacizumab 133Cytarabine 128Capecitabine 124Temozolomide 123Specimen Handling 122Radiosurgery 117Docetaxel 116Biopsy 115Ipilimumab 114Dexamethasone 113Radiation 109Oxaliplatin 109Fluorouracil 109Etoposide 108Rituximab 107Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × OTHER × laromustine × Clear all
NCT00521859 2012-07-31

Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
5 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT00516282 2011-08-26

VNP40101M and Temozolomide in Treating Patients With Progressive or Relapsed Malignant Glioma

Northwestern University

Phase 1 Terminated
14 enrolled
CNSSarcoma

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡